Skip to Main Content
Skip Nav Destination
Article navigation

It has been found that normal rabbits respond to the intravenous administration of Cx-reactive protein by producing this acute phase substance. When Cx-reactive protein incorporated in adjuvant is injected intracutaneously, in addition to producing Cx-reactive protein, the recipient animals develop a characteristic inflammatory reaction about the site of injection. This inflammatory reaction can be inhibited by the prior intravenous injection of thorotrast.

This content is only available as a PDF.
You do not currently have access to this content.
Don't already have an account? Register

or Create an Account

Close Modal
Close Modal